.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
US Department of Justice
Farmers Insurance
Merck
Chubb
Fish and Richardson
Cipla
Cerilliant
Daiichi Sankyo
Express Scripts

Generated: November 19, 2017

DrugPatentWatch Database Preview

Precision Dermat Company Profile

« Back to Dashboard

What is the competitive landscape for PRECISION DERMAT, and when can generic versions of PRECISION DERMAT drugs launch?

PRECISION DERMAT has eight approved drugs.

There are three US patents protecting PRECISION DERMAT drugs on PRECISION DERMAT drugs in the past three years.

There are twenty-eight patent family members on PRECISION DERMAT drugs in twenty-two countries and eleven supplementary protection certificates in ten countries.

Summary for Precision Dermat

International Patents:28
US Patents:3
Tradenames:4
Ingredients:3
NDAs:8
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Precision Dermat
MINOCIN
minocycline hydrochloride
CAPSULE;ORAL050649-001May 31, 1990ABRXNoNo► Subscribe► Subscribe► Subscribe
Precision Dermat
LOCOID
hydrocortisone butyrate
SOLUTION;TOPICAL019116-001Feb 25, 1987ATRXYesYes► Subscribe► Subscribe► Subscribe
Precision Dermat
MINOCIN
minocycline hydrochloride
CAPSULE;ORAL050649-002May 31, 1990ABRXNoNo► Subscribe► Subscribe► Subscribe
Precision Dermat
LOCOID
hydrocortisone butyrate
LOTION;TOPICAL022076-001May 18, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
Precision Dermat
LOCOID
hydrocortisone butyrate
LOTION;TOPICAL022076-001May 18, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
Precision Dermat
LOCOID
hydrocortisone butyrate
OINTMENT;TOPICAL018652-001Oct 29, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Precision Dermat
LOCOID LIPOCREAM
hydrocortisone butyrate
CREAM;TOPICAL020769-001Sep 8, 1997AB2RXYesYes► Subscribe► Subscribe► Subscribe
Precision Dermat
MINOCIN
minocycline hydrochloride
SUSPENSION;ORAL050445-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Precision Dermat
CLINDAGEL
clindamycin phosphate
GEL;TOPICAL050782-001Nov 27, 2000BTRXYesYes► Subscribe► SubscribeY ► Subscribe
Precision Dermat
LOCOID
hydrocortisone butyrate
CREAM;TOPICAL018514-001Mar 31, 1982AB1RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Precision Dermat

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Precision Dermat
LOCOID LIPOCREAM
hydrocortisone butyrate
CREAM;TOPICAL020769-001Sep 8, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for PRECISION DERMAT drugs

Drugname Dosage Strength Tradename Submissiondate
hydrocortisone butyrate
Lotion0.1%
LOCOID
8/31/2016
hydrocortisone butyrate
Cream0.1%
LOCOID LIPOCREAM
6/28/2010

Premature patent expirations for PRECISION DERMAT

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
► Subscribe ► Subscribe

Non-Orange Book Patents for Precision Dermat

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,517,847 Topical gel delivery system► Subscribe
8,546,364Stabilized steroid composition and method for its preparation► Subscribe
8,389,502Stabilized steroid composition and method for its preparation► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Precision Dermat Drugs

Country Document Number Estimated Expiration
Cyprus1109189► Subscribe
Australia7900201► Subscribe
Hong Kong1125847► Subscribe
South Korea100840169► Subscribe
Portugal2052714► Subscribe
Denmark2052714► Subscribe
Austria429922► Subscribe
Canada2417646► Subscribe
China1460013► Subscribe
South Korea20030057526► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Precision Dermat Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013025Lithuania► SubscribePRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
C/GB10/012United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
401Luxembourg► SubscribePRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
1304992/01Switzerland► SubscribePRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
13/044Ireland► SubscribePRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
2013 00053Denmark► SubscribePRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
2013025,C1304992Lithuania► SubscribePRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
00617Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
4Finland► Subscribe
C0038France► SubscribePRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Julphar
QuintilesIMS
Cipla
Covington
McKesson
Colorcon
US Department of Justice
Chubb
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot